Comparison of genetic variations of the SLCO1B1, SLCO1B3, and SLCO2B1 genes among five ethnic groups

References

Page 1

	Year	Citations
Haploview: analysis and visualization of LD and haplotype maps Jeffrey C. Barrett, Ben Fry, Julian Maller, Bioinformatics	2004	14.5K
<i>SLCO1B1</i> Variants and Statin-Induced Myopathy — A Genomewide Study New England Journal of Medicine	2008	2K
A Comparison of Linkage Disequilibrium Measures for Fine-Scale Mapping Bernie Devlin, Neil Risch Genomics	1995	1K
Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics Yohei Nishizato Clinical Pharmacology & Therapeutics	2003	510
The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy Russell A. Wilke, Laura B. Ramsey, Samuel G. Johnson, Clinical Pharmacology & Therapeutics	2012	324
Human Organic Anion Transporting Polypeptide-C (SLC21A6) Is a Major Determinant of Rifampin-Mediated Pregnane X Receptor Activation Rommel G. Tirona, Brenda F. Leake, Allan W. Wolkoff, Journal of Pharmacology and Experimental Therapeutics	2003	323
Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response Edward B. Mougey, Hua Feng, Mario Castro, Pharmacogenetics and Genomics	2009	190
Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8) Katrin Letschert, Dietrich Keppler, Jörg König Pharmacogenetics	2004	186
The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans Junko Imanaga, Tsutomu Kotegawa, Hiromitsu Imai, Pharmacogenetics and Genomics	2010	179
The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics Nicolas Picard, Sook Wah Yee, Jean‐Baptiste Woillard, Clinical Pharmacology & Therapeutics	2009	164

Page 1